BEUDAMED
    FDA Adverse Event Death Summary report: N

    MUGARD ORAL RINSE 240ML/BTL

    MDR report key: 21200512 · Received January 21, 2025

    Report

    Report Number
    MW5164997
    Event Type
    Death
    Date Received
    January 21, 2025
    Report Date
    January 16, 2025
    Manufacturer
    SOLEVA PHARMA LLC.
    Product Code
    MGQ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Description of Event or Problem · 0

    EVENT: THE PATIENT WAS MARKED DECEASED IN WALGREENS RETAIL SYSTEM WHICH FLOWED TO WALGREENS SPECIALTY SYSTEM AND WE ARE REPORTING PER CONTRACTUAL REQUIREMENTS AND STANDARD OPERATING PROCEDURE WITHIN ONE BUSINESS DAY; HOWEVER, NO CAUSE OF DEATH KNOWN, DATE OF DEATH UNKNOWN AND NO FURTHER INFORMATION AVAILABLE. FREQ: SWISH AND EXPEL OR SWALLOW 5-10 ML 4-6 TIMES DAILY AS DIRECTED FOR MUCOSITIS. MALIGNANT NEOPLASM OF LIVER, PRIMARY, UNSPECIFIED AS TO TYPE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    708728 MUGARD ORAL RINSE 240ML/BTL DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC MGQ SOLEVA PHARMA LLC.

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Male Death ALLOPURINOL TAB 100MG| CALCIUM / MAGN TAB 250-155| COQ10 CAP 100MG| CRANBERRY TAB 500MG| FARXIGA TAB 10MG| FINASTERIDE TAB 5MG| FLONASE ALGY SPR 50MCG| GINGER ROOT CAP 500MG| GLUCOSAMINE TAB 750MG| LUTEIN CAP 20MG